Sponsored

Investment in change management is key to harnessing real value from artificial intelligence, say CVC Capital Partners’ Jean-Rémy Roussel and Andrea Peyracchia.

Private equity’s interventionist approach is accelerating AI adoption across portfolio companies, as GPs also explore applications in their own operations, say Bridget Walsh, Kenneth Woodruff and Prashant Garg at EY.

As the secondaries market segments into different risk/return strategies, LPs may need to become more granular in their approach to the asset class, say Ignacio de la Mora and Derek Snyder, partners at AltamarCAM Partners.

While LP appetites for China are somewhat diminished, excitement is growing around India and Japan.

Evolutions in the secondaries market have led to different levels of growth in its various subsegments, says Nate Walton, partner and head of private equity secondaries at Ares Management

Private equity firms are strengthening and leveraging their internal skill sets and focusing on value creation within their tech portfolios while they wait for exit conditions to improve, says Baker McKenzie’s Eric Schwartzman.

As more capital becomes available to build on Europe’s long history of healthcare innovation, the market is gearing up for the next stage of growth, say Geraldine O’Keeffe and Dr Mark Braganza at EQT.

Private equity firms can tap into shifting industry dynamics to generate value across their healthcare portfolios, say Deloitte Consulting’s Teresa Leste and Sagar Patel.

Tech enablement is having a transformative impact on the healthcare sector, helping to reduce costs and improve outcomes, says Permira principal Dimitrios Tzivelis.

In this second episode of the third season of the Disruption Matters podcast miniseries, we look at how technology is changing the nature of due diligence and improving investment decisions.